Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CON
CON logo

CON Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Concentra Group Holdings Parent Inc (CON) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
22.880
1 Day change
0.09%
52 Week Range
24.680
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Concentra Group Holdings Parent Inc (CON) does not present a compelling buy opportunity for a beginner, long-term investor at this time. While the company has shown strong revenue and net income growth in its latest quarter, the stock's technical indicators and options data suggest limited short-term upside, and there are no strong proprietary trading signals to support immediate action. Additionally, the retirement of a key executive introduces uncertainty about the company's strategic direction.

Technical Analysis

The stock shows bullish moving averages (SMA_5 > SMA_20 > SMA_200), and the MACD histogram is positive but contracting, indicating weakening momentum. RSI is neutral at 58.002, and the stock is trading near its pivot level of 21.805, with resistance at 22.73. However, the stock's trend analysis indicates a 60% probability of a decline in the short term (-1.94% next day, -3.41% next week, -3.17% next month).

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
4
Buy
10

Positive Catalysts

  • Strong Q4 financial performance with revenue up 15.92% YoY and net income up 58.05% YoY. Analysts have raised the price target to $31, citing the company's inherent stability and above-consensus Q4 results.

Neutral/Negative Catalysts

  • The Chief Medical Officer's retirement introduces uncertainty about the company's strategic direction. EPS dropped significantly (-74.26% YoY), and gross margin slightly declined (-0.67% YoY). Short-term stock trend analysis suggests a likelihood of price decline.

Financial Performance

In Q4 2025, revenue increased to $539.08M (+15.92% YoY), and net income rose to $33.99M (+58.05% YoY). However, EPS dropped to 0.26 (-74.26% YoY), and gross margin decreased slightly to 22.34 (-0.67% YoY).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

RBC Capital raised the price target to $31 from $30 and maintains an Outperform rating, citing strong Q4 results and inherent business stability.

Wall Street analysts forecast CON stock price to rise
4 Analyst Rating
Wall Street analysts forecast CON stock price to rise
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 22.860
sliders
Low
27
Averages
28.67
High
30
Current: 22.860
sliders
Low
27
Averages
28.67
High
30
RBC Capital
Outperform
maintain
$30 -> $31
AI Analysis
2026-02-02
Reason
RBC Capital
Price Target
$30 -> $31
AI Analysis
2026-02-02
maintain
Outperform
Reason
RBC Capital raised the firm's price target on Concentra to $31 from $30 and keeps an Outperform rating on the shares. The firm cites the company's above-consensus Q4 pre-announcement and initial FY26 guide, the analyst tells investors in a research note. The solid Q4 print reflects inherent stability in the business model, even amid macroeconomic uncertainty, the firm added.
Bernstein
Harry Martin
Underperform -> Market Perform
upgrade
2026-01-05
Reason
Bernstein
Harry Martin
Price Target
2026-01-05
upgrade
Underperform -> Market Perform
Reason
Bernstein analyst Harry Martin upgraded Continental AG to Market Perform from Underperform with a price target of EUR 66, up from EUR 50. The firm says the tire makers offer investors a "highly attractive" part of the autos value chain with a positive setup into 2026.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CON
Unlock Now

People Also Watch